The Cancer Treatment Centers of America continues its 19 years of medical expertise to astronomical heights. CTCA is now working with Allscripts, NantHealth Inc., and eviti to combine their unique skill sets to provide healthcare seen no where else.
CTCA delivers the highest possible care and treatment for adults fighting cancer. Using their resources and knowledge to improve quality and effectiveness of treatments for patients. Allscripts connects healthcare solutions to people of all demographics. NantHealth delivers the best protocol for a given illness based on an individuals molecules. And Eviti is a system connecting oncologists rapidly to treatments, costs, outcomes, and evidence on the solutions given effectiveness. The combination of all these powerful institutions is the newly formed Clinical Pathways system.
Clinical Pathways system is a stream of intelligence of healthcare solutions catered to the molecules of an individual seen by doctors, showing both the outcome, evidence of effectiveness, and cost to deliver to patients. At first sight of care doctors can now issue solutions rapidly and speed up the process and effectiveness for treatment. Ironically with all the data comprised and available, the Clinical Pathways system actually reduces the options for variables in treatment. Giving each patient an almost exclusive and individualized treatment regiment for them and them alone. Of course it can be helpful to others, but it is tailor specifically to that persons needs. Since CTCA is only located in 5 cities, the Clinical Pathways can only be used by patients at those locations.
CTCA has always been changing how to do healthcare, but this is revolutionary. With more patients being helped and the functionality of the Clinical Pathways system operating, the more effective it will become. In due time, this system can be adopted in other medical institutions allotting more doctors time to help more people.
Prostate cancer has become the most frequent cancer in men. Beginning Sept. 1 through Oct. 15, 2000 men, ages 40 and older, who meet eligibility conditions, could join and get a completely free Prostate Specific Antigen (PSA) screening by LabCorp at some one of its 1,750 locations all through the U. S. After the initial 2000 free PSA screening, areas that are full of qualified guys could still envision receiving a screening at the reduced cost of $25 during the signup period. Screenings have to be carried out within half an hour of this signup date.
Nearly one out of every seven guys will be diagnosed with the terrible disease of prostate cancer within their whole life, the American Cancer Society estimates that there will probably soon be 161,360 brand new prostate cancer diagnoses from 2017. This is a very high prospective number and presents a sever risk in society. Risk factors include family background and race. Together, with African American men accounting for significantly more than 70 per cent higher odds of developing prostate cancer, the remainder of men in society have been posed with a serious risk. The cancer society of America is looking to lower these numbers and prevent such a terrible disease.
As a portion of this Prostate pep-talk effort will go to a charitable cause, the NFL hopes to present a greater level of awareness. Public service announcements containing celebrated former NFL head coaches Herm Edwards, Dick Vermeil, along with Bill Cowher increases awareness of prostate cancer risks and invites men to get screened for this disorder. The General Public service announcements will be broadcast nationwide all through September. (That will be Prostate Cancer Awareness Month.) This new effort to stop prostate cancer is an excellent endeavor and one that aims to produce better health in society. Cancer awareness is very important.
Recently, Cancer Treatment Centres of America in Partnership with All Script and NantHealth came up with a custom oncology treatment platform. Using this platform, eviti, a NantHealth medical decision support system will be able to access all relevant clinical records from All scripts.
When the platform is fully set-up in place, it will be able to provide custom treatment to every single patient depending on the specific illness state. It will also be able to compare different treatment options for various patients putting into account the cost of each one of them. The platform will go a long way in combating cancer and helping cancer patients.
Headquartered in Boca Raton, Florida, the United States of America, Cancer Treatment Centres of America, is a network of hospitals comprising of 5 hospitals serving cancer patients. Offering interactive approach to cancer patients, Cancer Treatment Centres America provides services like surgery, radiation, and chemotherapy. The network of hospitals also provides immunotherapy all in a bid to treat and give the best care to cancer patients.
CTCA was established in 1988 by Richard J Stephenson after his mother died of cancer. Richard Stephenson was not satisfied with the services his mother had received before passing on. The first hospital opened under the network was at Midwestern Regional Medical Centre in Zion, Illinois. It was also at Illinois that the network’s first headquarters was located until it was moved to Boca Raton, Florida in 2015.
The other four hospitals in the network were opened between 2005 and 2012. South Western Regional Medical Centre in, Oklahoma, South-eastern Regional Medical Centre in Georgia and Western Regional Medical Centre in Arizona are some of these hospitals.
Cancer Treatment Centres of America has truly made a mark in the medical field especially when dealing with cancer patients. Among many other awards, CTCA has won the Top Performer on Key Quality Measures and the Magnet.
Healthcare charges in the United States have gone too high in the recent years compared to 1990s and before. Records show that $933 billion more was spent on healthcare in 2013 compared to 1996. Part of this figure could be attributed to an increase in population, but the effect of rising medical costs cannot be ignored. Aging is also a factor that contributes to increased doctor visits and a consequent increase in healthcare expenditure.
The JAMA Report
JAMA recently published a report on the analysis of expenditures related to healthcare. One peculiar thing about the report was that Americans were not seen to have changed the frequency in which they sought for medical services over the years. This means that besides the increase in population and the long life expectancy in America, the other prominent healthcare expenditure driver is increased charges. Gerard Anderson of the Bloomberg School of Public Health argued that prices shape the spending curve; the higher the cost, the higher the expenditure will be. Although Gerard took no active role in the 2013 research, he was part of a similar undertaking in 2003. He has been consistent since then that it is the prices that escalate spending, with the recent survey vindicating his claim.
Joseph Dieleman is of the opinion that different diseases come with various costs. Joseph, one of the senior professionals in the study, gave an example of diabetes whereby about $44 billion out of $64 billion was spent on pharmaceuticals. That said, it is clear that prevalence of diabetes has had a substantial impact on Americans’ expenditure. Another major finding in research was that even though the duration of patients’ hospital stay has reduced significantly, the cost associated with it has remained stagnant. Joseph Dieleman explained that this was an effect of the increase in daily hospital charges.
The Role of Lefkofsky
Eric Lefkofsky is a co-founder of several firms including Tempus. The 48 years old native of Michigan has been on the front line in trying to find solutions to cancer-related problems. As the CEO of Tempus, Eric has played a key role in ensuring that clinical data on cancer patients is available for physicians’ future use.
Tempus was established only a couple of years back, and to this end, the firm is doing a wonderful job. Eric has led the company in getting partnership deals with institutions like the University of Michigan- his alma mater, Northwestern’s Lurie Cancer Center, and Cleveland Clinic among others. His passion towards helping cancer patients is driven by a personal experience with a cancer patient.
Ageing or aging is the process of becoming older until our bodies can no longer function properly and will stop working at some point.The most accepted theory, to this date, is that aging is the accumulation of damage that happens to the body of living things as time progresses, and their lives keep going until there is enough damage that they can no longer resist.This “accumulation of damage” is what causes cells, organisms and whole systems of the body to fail, while there also exist internal causes of damage that help deteriorate the tissues of the body over time.However, an extensive study of the doctor Mikhail V. Blagosklonny has shown that this is not actually the case, but something completely different might be the cause of cancer as we know of it today.
According to his studies, aging is not an accumulation of damage, but it is a continuation of the process of growth that is experienced in the youth of men and women.As life progresses, the bodies of living beings grow as much as their DNA dictates, and their alimentation provides, but the DNA also dictates when the growth stops happening and the systems of the body start moving towards a period of life where deterioration happens naturally. One can live their lives eating healthily and not having external damage at all, but their body will still age because it is the natural course of what happens to all living beings.With these discoveries, however, Dr. Mikhail V. Blagosklonny has furthered his research into developing the next-gen anti-aging drug. As much as it sounds fantastic and utopic, the expert is actually reaching positive results to what might be the first remedy that actually slows down aging and prevents diseases that come with the process.
According to the specialist, the hyperfunction theory, as he likes to call it, allows scientists to now understand where the aging code comes from, and it can be traced back to signaling pathways such as what they call “TOR,” which stands for “Target of Rapamycin,” the name of the drug that is the scientist Blagosklonny developed Oncotarget .While it is an anti-aging drug of sorts, people might think that this is will make humans have some sort of immortal beings. Dr. Mikhail V. Blagosklonny addresses this issue when he explains that the drug he is developing simply slows down aging to abolish diseases like cancer that happen to old people more than younger ones. These diseases will not be the causes of death anymore, at least not of the same magnitude that it has been for years, but there will always exist additional events that cause the death of individuals.The TOR-Centric Model, which comprise the pathway that is essential for the growth and development of human beings, can be found in three different sources currently. The first one being the person’s genetics; the second being the cellular senescence (when the cycle of our body cells is blocked) because the rapamycin suppresses geroconversion. The third and last source of the TOR-Centric model are diseases like Parkinson and Alzheimer, for the surprise of most scientists.Today, Dr. Mikhail V. Blagosklonny is still furthering his researches to find out more about aging and the diseases that come with it.
Eric Paul Lefkofsky is a Chicago based entrepreneur, philanthropist and author. He began his entrepreneurial journey in 1993, after graduating from the University of Michigan where he studied law. Lefkofsky, together with his friend, Brad Keywell, began a company called Brandin Apparel where they sold carpets to their friends and college mates. The success of this venture gave him hope and a strong conviction that he could make it in the aggressive health care business world. He went ahead to launch various other companies like Groupon where he acted as its chairman and chief executive officer and Staberbelly. He also launched InnerWorkings in 2001 and Echo Global Logistics in 2005. The company was led with so much charisma and success that it attracted the New Enterprise Asociates and later on went public on NASDAQ.
Lefkosky’s greatest achievements is seen through the risk he took to begin a health company called Tempus. Having little knowledge on medicine and health, he began reading books and partnered with the right people to begin Tempus. Tempus is a tech company that provides solutions to doctors and physicians to help cure cancer. The company collects data and analyses it, after which the data is availed to the physicians who use it to help their patients who may be suffering from similar cases or tumour. Since its initiation in 2015, Lefkofsky has been the chief operating officer and its cofounder and has used his entrepreneurial skills to keep organization running, profitable and impactful to the society.
Lefkosky and his family are also popularly known for their commitment to helping their communities and impacting lives. Lefkofsky is engaged in various charity organizations where he spends both resources and time in. he began the Eric Lefkofsky Foundation in 2006, which is purposed to support organizations that are involved in charity science and education courses. He also supports and funds the Giving Pledge charity organization that is determined to provide food, clothing, shelter and medical supplies to those in need.
Lefkofsky is a man of many talents. Besides being a great leader, humanitarian he has also authored a book called the Accelerated Disruption which gives leaders insights on management of their businesses.
There are so many people who struggle on finding out what kind of treatments are best for you. Countless people and even physicians sometimes need that instant help in order to know what a person needs for their body and health. With the help of the Cancer Treatment Center of America working towards fixing this with new technology, they are definitely finding one solution one step at a time. They recently have released the Clinical Pathways program that is going to change how doctors work together with their patients in terms of what to do with their cancer.
According to Wikipedia, Clinical Pathways is a new solution that is going to update everybody in real-time what a patient needs based on their current state of health. Things like how their health is coping at the moment is going to be measured to ensure that any type of recommendations given is perfect for their health. All the cancer is tough to deal with, and Clinical Pathways is going to give physicians up to date knowledge on what to remember regarding what is best for their patients. There are custom treatment regimens available, comparisons between the options, alongside what knowing what is safe and most efficient for them. There is also a quick look at what is most cost-effective to think about regarding their health.
This Cancer Treatment Center of America is mainly focused on providing adults with solutions and treatments for their cancer. They aim to provide an integrative approach to combine powerful solutions for overcoming all kinds of cancer with advanced treatments, radiation, chemotherapy, and other forms of therapy to help adults overcome their biggest obstacles with their health. It’s important that they stay on their toes to help provide their patients with results, and they do it every day in all of their hospitals nationwide.
For more information follow Cancer Treatment Centers of America on Facebook.